Skip to main content

Cancer Drugs Fund under spend is costing lives

Radiopharmaceuticals more commonly known as radiotherapy is a precise/localised way of targeting cancer. It causes less damage to the tissues around the cancer area than chemotherapy because it is so precise/localised. Results show it is 8 times more successful than Chemotherapy. If you wish to geek out on original EU guidelines on the storage and safe usage of radiopharmaceuticals then please follow this link (here).

In October 2010, the Tories announced a cancer drugs fund of up to £200,000,000. This was a good decision and one which should have led to 1000s of lives throughout the 28 Cancer Network areas of England being saved. Conceivably, the £200m could have paid for this radiotherapy treatment. 

The sad fact is that there is currently a severe under spend in the Cancer Drugs Fund. Only £71,000,000 has been spent so far this year. Even the Tory newspapers accept that this is potentially costing thousands of lives per year (here). What's more, the Cancer Drug Networks of the North East, North West, Yorks & Humberside, South West and Midlands are missing out on this radiotherapy treatment. Instead patients in those regions are either being offered chemotherapy treatment, or are too ill to undergo that treatment. Especially for the latter category of patients, it is imperative that they have the radiotherapy treatment made available. Thus far, the only sites offering the treatment are 2 private clinics and three southern hospitals.

Tonight, we in Labour Left are launching a campaign to a) ensure all of the Cancer Drugs Fund is spent and that b) The spending is allocated fairly throughout the 28 Cancer Networks. This will allow local areas to decide if they wish to avail of this radiotherapy treatment. Our Chairperson, and Health Select Committee Member, Grahame Morris MP (Easington), has been making the case on the Committee and in lobbying the government for some time. Grahame argues, "It makes no sense for the Cancer Drugs Fund to under spend in this way and relinquish resources back to the central NHS pot". He also warned, "People are dying on Lansley's watch because they are not being offered treatments that could save their lives. It is an insult to their families to deny them this avenue especially when the funds are there". 

Thus far the government have shown flashes of willingness to engage on the issue. Unfortunately, of the £200m fund, the government retain £60m locally and decide how it should be spent. In addition, there is no requirement that the £140m is evenly spread, or that there is guidance given on the radiotherapy treatment. Paul Burstow claims that he is willing to set aside an additional £150m over 3 years but this has not materialized in DoH guidance on resources available for the Cancer Drugs Fun (see here).

Comments

Popular posts from this blog

clip on magnetic sunglasses visit here

Save with prescription glasses and sunglasses. Prescription eyeglasses with magnetic clip on sunglasses. A wide selection of colors and styles for every budget! -GlassesPoint. Prescription eyeglasses with magnetic clip on sunglasses. A wide selection of colors and styles for every budget! Free magnetic clip on with every pair of glasses.  The operator should contact lens Plano glasses a few days of Sun and Rx on the other person. Many people choose single vision lenses, designed for a specific use, such as prescription sunglasses. Clip-ons magnetic magnetic clip ons often come with their prescription glasses frames. Prescription glasses Goggles4u dollars from 29.99 with free shipping. Takumi neodium magnet glass features recipes that are light, strong and in. The combination of some normal prescription glasses and a pair of polarized glasses that glare-resistant to outdoor activities. clip on magnetic sunglasses visit here

The Tragedy of Underfunded Mental Health Care

Today’s Managing Health Care Costs Indicator is   19,900 The NY Times  on Friday had a deeply disturbing article on a murder that stunned the mental health community here in Massachusetts.    A long-term schizophrenic man, off his medicine and spiraling into incoherence, killed a young female counselor who was the sole worker at a group home in a Boston suburb.   His mother, who works at a Boston teaching hospital, was frantic with worry as her adult son, who had been arrested for assault multiple times, was becoming more psychotic.    It was hard for her to get anyone’s attention. The counselor was the first in her family to get a college degree, and had just decided to go to nursing school.    Now she’s dead – and her family had trouble scraping together the resources for a burial.   The schizophrenic will be imprisoned for the rest of his life – which ironically could be the best chance for him to get appropriate medical care. Both...

How a Well-Intended FDA Policy on Colchicine is Harming Patients

The road to hell is paved with good intentions. The FDA has reaffirmed the truth of this aphorism with its policy about Colchicine. Here's the story: I recently spoke with a friend who has a family member suffering from Familial Mediterranean Fever (FMF), an auto-inflammatory disorder, most commonly seen in eastern Mediterranean populations. The condition is characterized by recurrent painful inflammation of the abdomen, chest and joints, accompanied by fever. FMF is associated with mutation of a gene on chromosome 16 involved with regulating Pyrin, a protein that is part of the inflammatory response. There is no specific test for the disease. Diagnosis is made on the basis of symptoms, family history, and ruling out other conditions. Since the 1960s, Colchicine, a plant extract first used for treatment of gout two thousand years ago, has been used for treating FMF. As an ancient treatment widely used prior to formation of the FDA, Colchicine did not require FDA approval as a new ...